Stoke Therapeutics (STOK) Earnings Date & Reports

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodyâ€™s potential with RNA medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

STOK is expected to report earnings to fall 119.89% to -37 cents per share on August 11

Stoke Therapeutics STOK Stock Earnings Reports

Q2'25

Est.

$-0.38

Q1'25

Beat

by $1.82

Q4'24

Beat

by $0.37

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.09

The last earnings report on May 13 showed earnings per share of $1.90, beating the estimate of 8 cents. With 882.02K shares outstanding, the current market capitalization sits at 487.55M.

View a ticker or compare two or three

Compare

STOK